Iceland suspended the Moderna anti-Covid vaccine on Friday, citing moderately increased risks of heart inflammation, going further than its Nordic neighbors with only limited use of jabs.
“Since Pfizer vaccine supplies are sufficient in the region … the chief epidemiologist has decided not to use Moderna Vaccine in Iceland,” a statement published on the Directorate of Health’s website said.
“This decision was due to an increased incidence of myocarditis and pericarditis following vaccination with Moderna Vaccine, as well as vaccination using Pfizer/BioNTech,” the chief epidemiologist said in a statement.
For the past two months, Icelanders have been given a “virtually exclusive” introduction of Moderna Vaccine to Icelanders vaccinated with Janssen, a single-dose serum marketed by Johnson & Johnson of the US, as well as to elderly and immunocompromised people who have received two. form” is administering an additional dose. Second dose of vaccine.
It will not affect the vaccination campaign in the island of 370,000 residents, where 88 percent of the population over the age of 12 is already fully vaccinated.
From Thursday, Sweden and Finland also suspended the use of the Moderna vaccine, but only for people under the age of 30, due to the risk of inflammation of the myocardium, the heart muscle and the pericardium, the membrane covering the heart. .
Denmark and Norway have formally advised against it for those under the age of 18.
According to Swedish authorities, most of these swellings are benign and go away on their own, but it is recommended that medical advice be sought if symptoms occur.
(Except for the title, this story has not been edited by NB staff and is published from a syndicated feed.)